Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9534-9540
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9534
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9534
Figure 2 Baseline levels of serum C-terminal crosslinking telopeptide of type I collagen in controls and in patients with Crohn’s disease active or in remission.
CTX: C-terminal crosslinking telopeptide of type I collagen; CD: Crohn’s disease. aP < 0.05 vs control group.
- Citation: Karatzoglou I, Yavropoulou MP, Pikilidou M, Germanidis G, Akriviadis E, Papazisi A, Daniilidis M, Zebekakis P, Yovos JG. Postprandial response of bone turnover markers in patients with Crohn’s disease. World J Gastroenterol 2014; 20(28): 9534-9540
- URL: https://www.wjgnet.com/1007-9327/full/v20/i28/9534.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i28.9534